[Endovascular treatment of iliofemoral venous thrombosis].
L, U., JD, N., M, T., ST, H., N, E., & N, B. (2026). [Endovascular treatment of iliofemoral venous thrombosis].. Ugeskrift for laeger. https://doi.org/10.61409/V01260049
L U, JD N, M T, ST H, N E, N B. [Endovascular treatment of iliofemoral venous thrombosis].. Ugeskrift for laeger. 2026; doi: 10.61409/V01260049
L U, JD N, M T, et al. [Endovascular treatment of iliofemoral venous thrombosis].[J]. Ugeskrift for laeger. 2026. DOI: 10.61409/V01260049.
@article{l2026,
author = {Urbak L and Nielsen JD and Taudorf M and Heerwagen ST and Eldrup N and Bækgaard N},
title = {[Endovascular treatment of iliofemoral venous thrombosis].},
journal = {Ugeskrift for laeger},
year = {2026},
doi = {10.61409/V01260049},
note = {PMID: 42563698},
}
TY - JOUR AU - Urbak L AU - Nielsen JD AU - Taudorf M AU - Heerwagen ST AU - Eldrup N AU - Bækgaard N TI - [Endovascular treatment of iliofemoral venous thrombosis]. T2 - Ugeskrift for laeger PY - 2026 DO - 10.61409/V01260049 AN - PMID:42563698 ER -
Endovenous procedures have been shown to offer an effective treatment for Iliofemoral deep venous thrombosis with a clinically relevant reduction in postthrombotic syndrome (PTS) compared to anticoagulation alone. Catheter-based thrombolysis reduces the risk of PTS but has been shown to cause periprocedural bleeding in about 3%. This review finds that mechanical thrombectomy has emerged as an ideal technique, with thrombus extraction without bleeding and a significant reduction in PTS at 12 months. A large randomised controlled trial including this technique versus anticoagulation is ongoing.